DyAnsys

Focus: DyAnsys develops percutaneous electrical neurostimulation devices targeting pain management, metabolic diseases, and oncology indications. The company is publicly traded and operates in the medical device segment with a diversified pipeline across multiple therapeutic areas.

Metabolic Diseases Oncology Neurology

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About DyAnsys

AI assessmentNot Hiring

No open roles listed right now. Follow DyAnsys to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

11 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Primary Relief v 2.0

Post Operative Pain

N/A

Clinical Trials (1)

NCT03750357Percutaneous Electrical Nerve Stimulation (PENS) of the Auricle for Post Operative Pain Solution(POPS) - Cardiac Surgery

N/A

Help build intelligence for DyAnsys

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pioneer in neuromodulation with 11 active clinical programs spanning high-unmet-need indications including post-operative pain, peripheral neuropathy, and diabetes
Public company status provides stability, equity compensation opportunities, and established infrastructure for career progression
Diversified therapeutic portfolio reduces single-indication risk and creates cross-functional collaboration opportunities in neurology, oncology, and metabolic diseases

Watch Out For

Zero active job openings at time of analysis signals potential hiring freeze, reduced headcount, or organizational restructuring
Sparse financial and operational data (missing employee count, revenue, R&D spend, funding history) indicates either private operations despite public status or limited market disclosure

Generated by Claude from DyAnsys's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Device Name: ANSiscope

Diabetes

N/A

Clinical Trials (1)

NCT05199350Distinguishing Participant Groups Using Autonomic Dysfunction

N/A

ANSiStim

Labor Pain

N/A

Clinical Trials (1)

NCT02427139ANSiStim Study for Active Labor Pain

N/A

Device: ANSiScope Plus

Diabetes

N/A

Clinical Trials (1)

NCT04964921Distinguishing Patient Groups Using Autonomic Dysfunction

N/A

Drug Relief V

Alcohol Use Disorder

N/A

Clinical Trials (1)

NCT04106739A Study of New Treatment for Excessive Alcohol Users by Electric Stimulation of Nerves Around Ear

N/A

Primary Relief

Cancer of Endometrium

N/A

Clinical Trials (1)

NCT05742711Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients

N/A

ANSiscope

Supratentorial Brain Tumors

N/A

Clinical Trials (1)

NCT04094974Heartrate Variability and Intraoperative Brain Conditions in Supratentorial Tumors

N/A

Primary Relief

Arthroplasty, Knee Replacement

N/A

Clinical Trials (1)

NCT05416294Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries

N/A

First Relief Treatment

Peripheral Neuropathy

N/A

Clinical Trials (1)

NCT03540446First Relief Treatment for Peripheral Neuropathy

N/A

No intervention

Neurosurgical Patients

N/A

Clinical Trials (1)

NCT05230641Cardiac Autonomic Dysfunction and Perioperative Outcomes

N/A

Primary Relief v 2.0

Cesarean Section; Dehiscence

N/A

Clinical Trials (1)

NCT03829774To Study and Evaluate the Effectiveness of Treatment by Percutaneous Electrical NeuroStimulation (PENS) for Post-operative Pain in Cesarean Section Patients Using Primary Relief v 2.0

N/A